Personalis, Inc. Files 8-K Report
Ticker: PSNL · Form: 8-K · Filed: Nov 25, 2025 · CIK: 1527753
| Field | Detail |
|---|---|
| Company | Personalis, Inc. (PSNL) |
| Form Type | 8-K |
| Filed Date | Nov 25, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001, $4,266, $1,164 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, disclosure
Related Tickers: PSNL
TL;DR
PSNL filed an 8-K on 11/24/25 for 'Other Events' - details TBD.
AI Summary
On November 24, 2025, Personalis, Inc. filed an 8-K report. The filing indicates "Other Events" as the primary item of disclosure, with no specific details provided in the provided text regarding the nature of these events, any associated financial figures, or involved parties.
Why It Matters
This filing signifies a material event for Personalis, Inc. that requires public disclosure, though the specific nature of the event is not detailed in the provided excerpt.
Risk Assessment
Risk Level: low — The filing itself is a standard disclosure document and does not inherently present immediate financial risk without further context on the 'Other Events'.
Key Players & Entities
- Personalis, Inc. (company) — Registrant
- November 24, 2025 (date) — Date of earliest event reported
FAQ
What specific 'Other Events' are being reported by Personalis, Inc. in this 8-K filing?
The provided text of the 8-K filing does not specify the nature of the 'Other Events'.
What is the exact date of the earliest event reported in this 8-K?
The date of the earliest event reported is November 24, 2025.
What is the principal executive office address for Personalis, Inc.?
The principal executive offices are located at 6600 Dumbarton Circle, Fremont, California, 94555.
What is the IRS Employer Identification Number for Personalis, Inc.?
The IRS Employer Identification Number for Personalis, Inc. is 27-5411038.
Under which section of the Securities Exchange Act is this 8-K report filed?
This 8-K report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Stats: 470 words · 2 min read · ~2 pages · Grade level 13.3 · Accepted 2025-11-25 06:11:48
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share PSNL The Nasdaq
- $4,266 — MRD Recurrence Monitoring Test will be $4,266 and for the NeXT Personal Single Plasma
- $1,164 — sma Test the reimbursement rate will be $1,164. Medicare coverage for the NeXT Persona
Filing Documents
- d937100d8k.htm (8-K) — 22KB
- 0001193125-25-294454.txt ( ) — 129KB
- psnl-20251124.xsd (EX-101.SCH) — 3KB
- psnl-20251124_lab.xml (EX-101.LAB) — 17KB
- psnl-20251124_pre.xml (EX-101.PRE) — 11KB
- d937100d8k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Date: November 25, 2025 Personalis, Inc. By: /s/ Aaron Tachibana Aaron Tachibana Chief Financial Officer and Chief Operating Officer